{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:04:39Z","timestamp":1792029879521,"version":"4.4.0"},"reference-count":136,"publisher":"Georg Thieme Verlag KG","issue":"03","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Respir Crit Care Med"],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Sj\u00f6gren's disease (SjD) is a chronic, progressive autoimmune condition of exocrine and extraglandular tissues. It can present with isolated disease characterized by lymphocytic infiltration of salivary or lacrimal glands, but in approximately one-third of the patients, lymphocytic infiltration extends beyond exocrine glands to involve extraglandular organs such as the lungs. Pulmonary complications have been reported to occur between 9 and 27% of patients with SjD across studies. Respiratory manifestations occur on a spectrum of severity and include airways disease, interstitial lung disease, cystic lung disease, and lymphoma. Lung involvement can greatly affect patients' quality of life, has a major impact on the overall prognosis, and frequently leads to alteration in the treatment plans, highlighting the importance of maintaining a high index of clinical suspicion and taking appropriate steps to facilitate early recognition and intervention.<\/jats:p>","DOI":"10.1055\/s-0044-1785675","type":"journal-article","created":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T00:14:35Z","timestamp":1713226475000},"page":"397-410","source":"Crossref","is-referenced-by-count":8,"title":["Pulmonary Manifestations of Sj\u00f6gren's Disease"],"prefix":"10.1055","volume":"45","author":[{"given":"Louise","family":"Byrne","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, St. Vincent's University Hospital, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cormac","family":"McCarthy","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, St. Vincent's University Hospital, Dublin, Ireland"},{"name":"School of Medicine, University College Dublin, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurelie","family":"Fabre","sequence":"additional","affiliation":[{"name":"School of Medicine, University College Dublin, Dublin, Ireland"},{"name":"Department of Histopathology, St. Vincent's University Hospital, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishant","family":"Gupta","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care, and Sleep Medicine, University of Cincinnati, Cincinnati, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2024,4,15]]},"reference":[{"issue":"10","key":"ref1","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s00296-009-1152-8","article-title":"Lung involvement in patients with primary Sj\u00f6gren's syndrome: what are the predictors?","volume":"30","author":"V Yazisiz","year":"2010","journal-title":"Rheumatol Int"},{"issue":"01","key":"ref2","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/rheumatology\/kes311","article-title":"Clinical pulmonary involvement in primary Sjogren's syndrome: prevalence, quality of life and mortality\u2013a retrospective study based on registry data","volume":"52","author":"O Palm","year":"2013","journal-title":"Rheumatology (Oxford)"},{"issue":"04","key":"ref3","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/MD.0b013e318181e6af","article-title":"Primary Sj\u00f6gren syndrome in Spain: clinical and immunologic expression in 1010 patients","volume":"87","author":"M Ramos-Casals","year":"2008","journal-title":"Medicine (Baltimore)"},{"issue":"03","key":"ref4","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1378\/chest.70.3.354","article-title":"Pulmonary manifestations of Sj\u00f6gren's syndrome","volume":"70","author":"C V Strimlan","year":"1976","journal-title":"Chest"},{"issue":"04","key":"ref5","doi-asserted-by":"crossref","first-page":"303","DOI":"10.5606\/ArchRheumatol.2017.6160","article-title":"Chronic non-productive cough in patients with primary Sj\u00f6gren's syndrome","volume":"32","author":"G Do\u011fru","year":"2017","journal-title":"Arch Rheumatol"},{"issue":"12","key":"ref6","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1093\/rheumatology\/kev200","article-title":"Characterization of systemic disease in primary Sj\u00f6gren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements","volume":"54","author":"M Ramos-Casals","year":"2015","journal-title":"Rheumatology (Oxford)"},{"issue":"05","key":"ref8","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1007\/s10067-018-3987-4","article-title":"Unexplained cough: it is time to rule out Sjogren's syndrome","volume":"37","author":"M Koslow","year":"2018","journal-title":"Clin Rheumatol"},{"issue":"02","key":"ref9","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.chest.2020.10.011","article-title":"Consensus guidelines for evaluation and management of pulmonary disease in Sj\u00f6gren's","volume":"159","author":"A S Lee","year":"2021","journal-title":"Chest"},{"issue":"06","key":"ref10","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1136\/annrheumdis-2016-209952","article-title":"Influence of geolocation and ethnicity on the phenotypic expression of primary Sj\u00f6gren's syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big Data Sj\u00f6gren Project Consortium","volume":"76","author":"P Brito-Zer\u00f3n","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"08","key":"ref11","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/1756-185X.13881","article-title":"Prevalence and risk factors of interstitial lung disease in patients with primary Sj\u00f6gren's syndrome: a systematic review and meta-analysis","volume":"23","author":"C He","year":"2020","journal-title":"Int J Rheum Dis"},{"issue":"07","key":"ref12","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.3390\/jcm12072586","article-title":"Interstitial lung disease and pulmonary damage in primary Sj\u00f6gren's syndrome: a systematic review and meta-analysis","volume":"12","author":"O Berardicurti","year":"2023","journal-title":"J Clin Med"},{"issue":"01","key":"ref13","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s40001-022-00828-3","article-title":"Biomarkers of interstitial lung disease associated with primary Sj\u00f6gren's syndrome","volume":"27","author":"L Weng","year":"2022","journal-title":"Eur J Med Res"},{"issue":"02","key":"ref14","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/rheumatology\/kex077","article-title":"Progression and mortality of interstitial lung disease in mixed connective tissue disease: a long-term observational nationwide cohort study","volume":"57","author":"S Reiseter","year":"2018","journal-title":"Rheumatology (Oxford)"},{"issue":"04","key":"ref15","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.21037\/jtd.2018.03.120","article-title":"Risk factors for primary Sj\u00f6gren syndrome-associated interstitial lung disease","volume":"10","author":"Y Wang","year":"2018","journal-title":"J Thorac Dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jaut.2012.01.008","article-title":"Genetics of Sj\u00f6gren's syndrome in the genome-wide association era","volume":"39","author":"J A Ice","year":"2012","journal-title":"J Autoimmun"},{"issue":"07","key":"ref17","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1002\/art.39127","article-title":"Familial risk of Sj\u00f6gren's syndrome and co-aggregation of autoimmune diseases in affected families: a nationwide population study","volume":"67","author":"C F Kuo","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"06","key":"ref18","doi-asserted-by":"crossref","first-page":"748","DOI":"10.7326\/0003-4819-101-6-748","article-title":"Primary Sj\u00f6gren's syndrome and other autoimmune diseases in families. Prevalence and immunogenetic studies in six kindreds","volume":"101","author":"J D Reveille","year":"1984","journal-title":"Ann Intern Med"},{"issue":"05","key":"ref19","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/1756-185X.12398","article-title":"Primary Sj\u00f6gren's syndrome in monozygotic twins","volume":"17","author":"W S Lee","year":"2014","journal-title":"Int J Rheum Dis"},{"issue":"09","key":"ref20","first-page":"2264","article-title":"Monozygotic twins with primary Sj\u00f6gren's syndrome","volume":"27","author":"A I Bolstad","year":"2000","journal-title":"J Rheumatol"},{"issue":"04","key":"ref21","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.rdc.2008.08.003","article-title":"Genes and Sj\u00f6gren's syndrome","volume":"34","author":"B L Cobb","year":"2008","journal-title":"Rheum Dis Clin North Am"},{"issue":"09","key":"ref22","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1002\/art.27564","article-title":"Significance of B cells and B cell clonality in Sj\u00f6gren's syndrome","volume":"62","author":"P Youinou","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"02","key":"ref23","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1182\/blood.V90.2.766","article-title":"Lymphomas in patients with Sjogren's syndrome are marginal zone B-cell neoplasms, arise in diverse extranodal and nodal sites, and are not associated with viruses","volume":"90","author":"B Royer","year":"1997","journal-title":"Blood"},{"issue":"06","key":"ref24","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1093\/rheumatology\/key360","article-title":"Innate immunity and interferons in the pathogenesis of Sj\u00f6gren's syndrome","volume":"60","author":"I LA Bodewes","year":"2021","journal-title":"Rheumatology (Oxford)"},{"issue":"04","key":"ref25","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10238-020-00637-0","article-title":"Expression of BAFF and BAFF receptors in primary Sj\u00f6gren's syndrome patients with ectopic germinal center-like structures","volume":"20","author":"F J Carrillo-Ballesteros","year":"2020","journal-title":"Clin Exp Med"},{"issue":"06","key":"ref26","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1007\/s00330-001-1236-7","article-title":"Thin-section chest CT findings of primary Sj\u00f6gren's syndrome: correlation with pulmonary function","volume":"12","author":"B Taouli","year":"2002","journal-title":"Eur Radiol"},{"issue":"05","key":"ref27","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/MD.0b013e3181579781","article-title":"Pulmonary arterial hypertension: a rare complication of primary Sj\u00f6gren syndrome: report of 9 new cases and review of the literature","volume":"86","author":"D Launay","year":"2007","journal-title":"Medicine (Baltimore)"},{"issue":"02","key":"ref28","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S2213-2600(17)30433-2","article-title":"Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper","volume":"6","author":"D A Lynch","year":"2018","journal-title":"Lancet Respir Med"},{"issue":"02","key":"ref29","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ejrad.2004.01.006","article-title":"High-resolution CT imaging of the lung for patients with primary Sjogren's syndrome","volume":"52","author":"C Lohrmann","year":"2004","journal-title":"Eur J Radiol"},{"issue":"02","key":"ref30","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00004728-199903000-00002","article-title":"Air trapping in primary Sj\u00f6gren syndrome: correlation of expiratory CT with pulmonary function tests","volume":"23","author":"T Franquet","year":"1999","journal-title":"J Comput Assist Tomogr"},{"issue":"04","key":"ref31","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1159\/000214841","article-title":"Pulmonary manifestations of Sj\u00f6gren's syndrome","volume":"78","author":"J H Shi","year":"2009","journal-title":"Respiration"},{"issue":"09","key":"ref32","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1136\/ard.59.9.709","article-title":"Ten year follow up of pulmonary function in patients with primary Sj\u00f6gren's syndrome","volume":"59","author":"B K Davidson","year":"2000","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"ref33","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1007\/s10067-018-4289-6","article-title":"A retrospective analysis of distinguishing features of chest HRCT and clinical manifestation in primary Sj\u00f6gren's syndrome-related interstitial lung disease in a Chinese population","volume":"37","author":"X Dong","year":"2018","journal-title":"Clin Rheumatol"},{"issue":"35","key":"ref34","doi-asserted-by":"crossref","first-page":"e26777","DOI":"10.1097\/MD.0000000000026777","article-title":"Characteristics and mortality in primary Sj\u00f6gren syndrome-related interstitial lung disease","volume":"100","author":"H Gao","year":"2021","journal-title":"Medicine (Baltimore)"},{"issue":"07","key":"ref35","first-page":"513","article-title":"Lung involvement of primary Sj\u00f6gren's syndrome [in Chinese]","volume":"31","author":"S M Yan","year":"2008","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"issue":"01","key":"ref36","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.autrev.2016.09.017","article-title":"Interstitial lung disease in primary Sj\u00f6gren's syndrome","volume":"16","author":"F Roca","year":"2017","journal-title":"Autoimmun Rev"},{"issue":"01","key":"ref37","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12890-022-01868-5","article-title":"Interstitial lung disease in primary Sj\u00f6gren's syndrome","volume":"22","author":"W Lin","year":"2022","journal-title":"BMC Pulm Med"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"105895","DOI":"10.1016\/j.rmed.2020.105895","article-title":"Anti-Ro52 antibodies are a risk factor for interstitial lung disease in primary Sj\u00f6gren syndrome","volume":"163","author":"C Buvry","year":"2020","journal-title":"Respir Med"},{"issue":"10","key":"ref39","first-page":"1254","article-title":"Lung injury in idiopathic pulmonary fibrosis and measurement of immunoreactive neutrophil elastase and alpha 1-protease inhibitor in blood [in Japanese]","volume":"29","author":"K Kusume","year":"1991","journal-title":"Nihon Kyobu Shikkan Gakkai Zasshi"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"105811","DOI":"10.1016\/j.rmed.2019.105811","article-title":"Prognostic factors for primary Sj\u00f6gren's syndrome-associated interstitial lung diseases","volume":"159","author":"Y Kamiya","year":"2019","journal-title":"Respir Med"},{"issue":"11","key":"ref41","doi-asserted-by":"crossref","first-page":"e003569","DOI":"10.1136\/bmjopen-2013-003569","article-title":"Primary Sjogren's syndrome 1976-2005 and associated interstitial lung disease: a population-based study of incidence and mortality","volume":"3","author":"C Nannini","year":"2013","journal-title":"BMJ Open"},{"issue":"07","key":"ref42","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.autrev.2015.03.004","article-title":"Clinical picture, outcome and predictive factors of lymphoma in Sj\u04e7gren syndrome","volume":"14","author":"A Papageorgiou","year":"2015","journal-title":"Autoimmun Rev"},{"issue":"05","key":"ref43","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","article-title":"Diagnosis of idiopathic pulmonary fibrosis. an official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"198","author":"G Raghu","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"03","key":"ref44","first-page":"280","article-title":"Comparison of transbronchial and open biopsies in chronic infiltrative lung diseases","volume":"123","author":"C P Wall","year":"1981","journal-title":"Am Rev Respir Dis"},{"issue":"06","key":"ref45","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1164\/rccm.200403-417OC","article-title":"Pulmonary manifestations of primary Sjogren's syndrome: a clinical, radiologic, and pathologic study","volume":"171","author":"I Ito","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"issue":"09","key":"ref46","doi-asserted-by":"crossref","first-page":"e73774","DOI":"10.1371\/journal.pone.0073774","article-title":"Prognostic factors in interstitial lung disease associated with primary Sj\u00f6gren's syndrome: a retrospective analysis of 33 pathologically-proven cases","volume":"8","author":"Y Enomoto","year":"2013","journal-title":"PLoS One"},{"issue":"09","key":"ref47","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1164\/ajrccm.164.9.2103074","article-title":"Histopathologic variability in usual and nonspecific interstitial pneumonias","volume":"164","author":"K R Flaherty","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"05","key":"ref49","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1378\/chest.130.5.1489","article-title":"Interstitial lung disease in primary Sj\u00f6gren syndrome","volume":"130","author":"J G Parambil","year":"2006","journal-title":"Chest"},{"issue":"01","key":"ref50","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1164\/rccm.201411-2096CI","article-title":"Diffuse cystic lung disease. Part II","volume":"192","author":"N Gupta","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"ref51","first-page":"102","volume-title":"The interstitial pneumonias","author":"A A Liebow","year":"1969"},{"issue":"02","key":"ref52","first-page":"277","article-title":"American Thoracic Society\/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001","volume":"165","author":"American Thoracic Society","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"issue":"05","key":"ref53","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2559.1995.tb00247.x","article-title":"Reactive pulmonary lymphoid disorders","volume":"26","author":"A G Nicholson","year":"1995","journal-title":"Histopathology"},{"issue":"03","key":"ref54","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1148\/radiology.212.3.r99se04637","article-title":"Follicular bronchiolitis: thin-section CT and histologic findings","volume":"212","author":"S J Howling","year":"1999","journal-title":"Radiology"},{"issue":"04","key":"ref55","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/00005382-200110000-00010","article-title":"Pulmonary involvement in primary Sj\u00f6gren's syndrome: spectrum of pulmonary abnormalities and computed tomography findings in 60 patients","volume":"16","author":"M Koyama","year":"2001","journal-title":"J Thorac Imaging"},{"issue":"03","key":"ref56","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.chest.2016.05.015","article-title":"Cystic lung disease among patients with Sj\u00f6gren Syndrome: frequency, natural history, and associated risk factors","volume":"150","author":"C D Mart\u00ednez-Balzano","year":"2016","journal-title":"Chest"},{"issue":"912","key":"ref57","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1259\/bjr\/18937619","article-title":"Pulmonary lesions associated with Sj\u00f6gren's syndrome: radiographic and CT findings","volume":"76","author":"N Matsuyama","year":"2003","journal-title":"Br J Radiol"},{"issue":"04","key":"ref58","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/00005382-200110000-00009","article-title":"Lung manifestation in asymptomatic patients with primary Sj\u00f6gren syndrome: assessment with high resolution CT and pulmonary function tests","volume":"16","author":"M Uffmann","year":"2001","journal-title":"J Thorac Imaging"},{"issue":"02","key":"ref59","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3899\/jrheum.090507","article-title":"Pulmonary manifestations in Sjogren's syndrome: correlation analysis between chest computed tomographic findings and clinical subsets with poor prognosis in 80 patients","volume":"37","author":"M Watanabe","year":"2010","journal-title":"J Rheumatol"},{"issue":"02","key":"ref60","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3109\/00313028709077131","article-title":"Lymphoid interstitial pneumonia: clinicopathological and immunopathological findings in 18 cases","volume":"19","author":"M N Koss","year":"1987","journal-title":"Pathology"},{"issue":"02","key":"ref61","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/00007890-199407270-00013","article-title":"Interstitial pneumonitis and lymphocytic bronchiolitis\/bronchitis as a direct result of acute lethal graft-versus-host disease duplicate the histopathology of lung allograft rejection","volume":"58","author":"D L Workman","year":"1994","journal-title":"Transplantation"},{"issue":"05","key":"ref62","first-page":"287","article-title":"Lymphocytic interstitial pneumonia and associated cystic lung diseases","volume":"53","author":"E Lynn","year":"2020","journal-title":"Radiol Bras"},{"issue":"03","key":"ref63","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0025-7125(16)32278-7","article-title":"Diffuse pulmonary lymphoreticular infiltrations associated with dysproteinemia","volume":"57","author":"A A Liebow","year":"1973","journal-title":"Med Clin North Am"},{"issue":"02","key":"ref64","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1148\/radiology.212.2.r99au05567","article-title":"Lymphocytic interstitial pneumonia: thin-section CT findings in 22 patients","volume":"212","author":"T Johkoh","year":"1999","journal-title":"Radiology"},{"issue":"01","key":"ref65","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2214\/ajr.173.1.10397102","article-title":"Differential diagnosis of lymphocytic interstitial pneumonia and malignant lymphoma on high-resolution CT","volume":"173","author":"O Honda","year":"1999","journal-title":"AJR Am J Roentgenol"},{"issue":"03","key":"ref66","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1513\/AnnalsATS.201511-759BC","article-title":"Diffuse cystic lung disease as the presenting manifestation of Sj\u00f6gren syndrome","volume":"13","author":"N Gupta","year":"2016","journal-title":"Ann Am Thorac Soc"},{"issue":"06","key":"ref67","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1378\/chest.122.6.2150","article-title":"Lymphoid interstitial pneumonia: a narrative review","volume":"122","author":"J J Swigris","year":"2002","journal-title":"Chest"},{"key":"ref68","first-page":"837190","article-title":"A rare cause of diffuse parenchymal lung disease together with granulomatous reaction: pulmonary amyloidosis","volume":"2013","author":"Z Ozer Simsek","year":"2013","journal-title":"Case Rep Pulmonol"},{"issue":"05","key":"ref69","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/j.1440-1843.2010.01772.x","article-title":"Pulmonary amyloidosis in Sjogren's syndrome: a case report and systematic review of the literature","volume":"15","author":"S Rajagopala","year":"2010","journal-title":"Respirology"},{"issue":"03","key":"ref70","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2174\/1573397113666170103152537","article-title":"Coexistance of amyloidosis and primary Sj\u00f6gren's syndrome: an overview","volume":"14","author":"G Hernandez-Molina","year":"2018","journal-title":"Curr Rheumatol Rev"},{"issue":"03","key":"ref71","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1378\/chest.77.3.411","article-title":"Nodular pulmonary infiltrate in a patient with Sj\u00f6gren's syndrome","volume":"77","author":"S M Polansky","year":"1980","journal-title":"Chest"},{"issue":"01","key":"ref72","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3899\/jrheum.140964","article-title":"Pulmonary nodular amyloidosis in Sj\u00f6gren syndrome","volume":"42","author":"R Carbone","year":"2015","journal-title":"J Rheumatol"},{"issue":"08","key":"ref73","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1016\/j.ejim.2008.07.029","article-title":"Multinodular pulmonary amyloidosis in primary Sj\u00f6gren's syndrome","volume":"19","author":"T N Adzi\u0107","year":"2008","journal-title":"Eur J Intern Med"},{"issue":"03","key":"ref74","first-page":"385","article-title":"Localised nodular pulmonary amyloidosis in a patient with sicca syndrome","volume":"55","author":"P Srinivas","year":"2000","journal-title":"Med J Malaysia"},{"issue":"02","key":"ref75","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1378\/chest.94.2.438","article-title":"Sj\u00f6gren's syndrome with multiple bullae and pulmonary nodular amyloidosis","volume":"94","author":"H Kobayashi","year":"1988","journal-title":"Chest"},{"issue":"04","key":"ref76","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1756-185X.2009.01436.x","article-title":"Pulmonary amyloidosis in Sj\u00f6gren's syndrome: a rare diagnosis for nodular lung lesions","volume":"12","author":"K Rodrigues","year":"2009","journal-title":"Int J Rheum Dis"},{"issue":"01","key":"ref77","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1378\/chest.12-0547","article-title":"Enlarging lung nodules and cysts in a 53-year-old woman with primary Sj\u00f6gren syndrome","volume":"143","author":"E M Kluka","year":"2013","journal-title":"Chest"},{"issue":"04","key":"ref78","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.rmed.2013.01.005","article-title":"Amyloid-associated cystic lung disease in primary Sj\u00f6gren's syndrome","volume":"107","author":"M Baqir","year":"2013","journal-title":"Respir Med"},{"issue":"04","key":"ref79","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2169\/internalmedicine.41.309","article-title":"Pulmonary MALT lymphoma with amyloid production in a patient with primary Sj\u00f6gren's syndrome","volume":"41","author":"N Nakamura","year":"2002","journal-title":"Intern Med"},{"issue":"03","key":"ref80","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00005382-199707000-00009","article-title":"Benign pulmonary lymphocytic infiltration and amyloidosis: computed tomographic and pathologic features in three cases","volume":"12","author":"S R Desai","year":"1997","journal-title":"J Thorac Imaging"},{"issue":"01","key":"ref81","first-page":"42","article-title":"Lymphoid infiltration and amyloidosis of lung in Sj\u00f6gren's syndrome","volume":"95","author":"H Bonner Jr","year":"1973","journal-title":"Arch Pathol"},{"issue":"07","key":"ref82","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1164\/rccm.200510-1620CR","article-title":"Pulmonary cystic disorder related to light chain deposition disease","volume":"173","author":"M Colombat","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"07","key":"ref83","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1513\/AnnalsATS.201404-137OC","article-title":"Lung transplantation for advanced cystic lung disease due to nonamyloid kappa light chain deposits","volume":"11","author":"S Hirschi","year":"2014","journal-title":"Ann Am Thorac Soc"},{"issue":"09","key":"ref84","doi-asserted-by":"crossref","first-page":"588","DOI":"10.21037\/atm-20-2708","article-title":"Pulmonary light chain deposition disease: a case series and literature review","volume":"8","author":"P Wei","year":"2020","journal-title":"Ann Transl Med"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"105896","DOI":"10.1016\/j.rmed.2020.105896","article-title":"Pulmonary nodular and cystic light chain deposition disease: a retrospective review of 10 cases","volume":"164","author":"M Baqir","year":"2020","journal-title":"Respir Med"},{"issue":"06","key":"ref86","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1136\/jclinpath-2015-203342","article-title":"Nodular pulmonary light chain deposition disease: an entity associated with Sj\u00f6gren syndrome or marginal zone lymphoma","volume":"69","author":"A V Arrossi","year":"2016","journal-title":"J Clin Pathol"},{"issue":"05","key":"ref87","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.crad.2015.01.002","article-title":"Pulmonary light-chain deposition disease: CT and pathology findings in nine patients","volume":"70","author":"S Sheard","year":"2015","journal-title":"Clin Radiol"},{"issue":"08","key":"ref88","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.autrev.2012.11.004","article-title":"Lymphocyte transformation and autoimmune disorders","volume":"12","author":"C Tarella","year":"2013","journal-title":"Autoimmun Rev"},{"issue":"20","key":"ref89","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1001\/archinte.165.20.2337","article-title":"The risk of lymphoma development in autoimmune diseases: a meta-analysis","volume":"165","author":"E Zintzaras","year":"2005","journal-title":"Arch Intern Med"},{"issue":"02","key":"ref90","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.intimp.2015.03.027","article-title":"How are we treating our systemic patients with primary Sj\u00f6gren syndrome? Analysis of 1120 patients","volume":"27","author":"H Gheitasi","year":"2015","journal-title":"Int Immunopharmacol"},{"issue":"06","key":"ref91","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1136\/ard.2005.041186","article-title":"Lymphoma and other malignancies in primary Sj\u00f6gren's syndrome: a cohort study on cancer incidence and lymphoma predictors","volume":"65","author":"E Theander","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"08","key":"ref92","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1002\/1529-0131(199908)42:8<1765::AID-ANR28>3.0.CO;2-V","article-title":"Malignant lymphoma in primary Sj\u00f6gren's syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sj\u00f6gren's Syndrome","volume":"42","author":"M Voulgarelis","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"06","key":"ref93","doi-asserted-by":"crossref","first-page":"888","DOI":"10.7326\/0003-4819-89-6-888","article-title":"Increased risk of lymphoma in sicca syndrome","volume":"89","author":"S S Kassan","year":"1978","journal-title":"Ann Intern Med"},{"issue":"02","key":"ref94","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1023\/A:1018472213872","article-title":"Elevated incidence of hematologic malignancies in patients with Sj\u00f6gren's syndrome compared with patients with rheumatoid arthritis (Finland)","volume":"8","author":"M Kauppi","year":"1997","journal-title":"Cancer Causes Control"},{"issue":"03","key":"ref95","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1182\/blood.V95.3.802.003k19_802_806","article-title":"Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed","volume":"95","author":"C Thieblemont","year":"2000","journal-title":"Blood"},{"issue":"07","key":"ref96","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1182\/blood-2002-04-1279","article-title":"Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue","volume":"101","author":"E Zucca","year":"2003","journal-title":"Blood"},{"issue":"10","key":"ref97","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.3899\/jrheum.110077","article-title":"Treatment of mucosa-associated lymphoid tissue lymphoma in Sjogren's syndrome: a retrospective clinical study","volume":"38","author":"R P Pollard","year":"2011","journal-title":"J Rheumatol"},{"issue":"05","key":"ref98","first-page":"647","article-title":"Bronchiectasis in primary Sj\u00f6gren's syndrome: prevalence and clinical significance","volume":"28","author":"M J Soto-Cardenas","year":"2010","journal-title":"Clin Exp Rheumatol"},{"issue":"02","key":"ref99","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1378\/chest.09-1140","article-title":"Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry","volume":"137","author":"D B Badesch","year":"2010","journal-title":"Chest"},{"issue":"10","key":"ref100","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nrcardio.2017.84","article-title":"Epidemiology and treatment of pulmonary arterial hypertension","volume":"14","author":"E MT Lau","year":"2017","journal-title":"Nat Rev Cardiol"},{"issue":"153","key":"ref101","doi-asserted-by":"crossref","first-page":"190023","DOI":"10.1183\/16000617.0023-2019","article-title":"Screening for pulmonary arterial hypertension in systemic sclerosis","volume":"28","author":"J Weatherald","year":"2019","journal-title":"Eur Respir Rev"},{"issue":"04","key":"ref102","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1183\/09031936.00182813","article-title":"Connective tissue disease-associated pulmonary arterial hypertension in Chinese patients","volume":"44","author":"Y-J Hao","year":"2014","journal-title":"Eur Respir J"},{"issue":"05","key":"ref103","first-page":"e80","article-title":"Pulmonary hypertension associated with rheumatic diseases: baseline characteristics from the Korean registry","volume":"15","author":"C H Jeon","year":"2012","journal-title":"Int J Rheum Dis"},{"issue":"05","key":"ref104","doi-asserted-by":"crossref","first-page":"1902157","DOI":"10.1183\/13993003.02157-2019","article-title":"Pulmonary arterial hypertension associated with primary Sj\u00f6gren's syndrome: a multicentre cohort study from China","volume":"56","author":"J Wang","year":"2020","journal-title":"Eur Respir J"},{"issue":"01","key":"ref105","doi-asserted-by":"crossref","first-page":"2200879","DOI":"10.1183\/13993003.00879-2022","article-title":"2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"61","author":"M Humbert","year":"2023","journal-title":"Eur Respir J"},{"issue":"02","key":"ref106","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/art.23303","article-title":"Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases","volume":"58","author":"X Jais","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"01","key":"ref107","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1378\/chest.130.1.182","article-title":"Immunosuppressive therapy in connective tissue diseases-associated pulmonary arterial hypertension","volume":"130","author":"O Sanchez","year":"2006","journal-title":"Chest"},{"issue":"06","key":"ref108","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1136\/ard.2009.110619","article-title":"EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome","volume":"69","author":"R Seror","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"ref109","first-page":"283","article-title":"Ten years of the ESSDAI: is it fit for purpose?","volume":"38","author":"L de Wolff","year":"2020","journal-title":"Clin Exp Rheumatol"},{"issue":"01","key":"ref110","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/annrheumdis-2019-216114","article-title":"EULAR recommendations for the management of Sj\u00f6gren's syndrome with topical and systemic therapies","volume":"79","author":"M Ramos-Casals","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1164\/ajrccm.154.3.8810621","article-title":"Interstitial lung disease in primary Sj\u00f6gren's syndrome. Clinical-pathological evaluation and response to treatment","volume":"154","author":"D Deheinzelin","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"issue":"06","key":"ref112","doi-asserted-by":"crossref","first-page":"2202071","DOI":"10.1183\/13993003.02071-2022","article-title":"Rituximab and mycophenolate mofetil combination in patients with interstitial lung disease (EVER-ILD): a double-blind, randomised, placebo-controlled trial","volume":"61","author":"J Mankikian","year":"2023","journal-title":"Eur Respir J"},{"issue":"04","key":"ref113","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/art.27314","article-title":"Effectiveness of rituximab treatment in primary Sj\u00f6gren's syndrome: a randomized, double-blind, placebo-controlled trial","volume":"62","author":"J M Meijer","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"04","key":"ref114","doi-asserted-by":"crossref","first-page":"233","DOI":"10.7326\/M13-1085","article-title":"Treatment of primary Sj\u00f6gren syndrome with rituximab: a randomized trial","volume":"160","author":"V Devauchelle-Pensec","year":"2014","journal-title":"Ann Intern Med"},{"issue":"11","key":"ref115","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1136\/ard.2007.083865","article-title":"Reduction of fatigue in Sj\u00f6gren syndrome with rituximab: results of a randomised, double-blind, placebo-controlled pilot study","volume":"67","author":"S Dass","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"07","key":"ref116","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1002\/art.40093","article-title":"Randomized controlled trial of rituximab and cost-effectiveness analysis in treating fatigue and oral dryness in primary Sj\u00f6gren's syndrome","volume":"69","author":"S J Bowman","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"06","key":"ref117","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1136\/annrheumdis-2012-202293","article-title":"Efficacy of rituximab in systemic manifestations of primary Sjogren's syndrome: results in 78 patients of the AutoImmune and Rituximab registry","volume":"72","author":"J E Gottenberg","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"ref118","doi-asserted-by":"crossref","first-page":"ii79","DOI":"10.1136\/ard.2004.028498","article-title":"The utility of tumour necrosis factor blockade in orphan diseases","volume":"63","author":"E C Keystone","year":"2004","journal-title":"Ann Rheum Dis"},{"issue":"04","key":"ref119","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/art.20146","article-title":"Inefficacy of infliximab in primary Sj\u00f6gren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sj\u00f6gren's Syndrome (TRIPSS)","volume":"50","author":"X Mariette","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"01","key":"ref120","first-page":"96","article-title":"Etanercept in the treatment of patients with primary Sj\u00f6gren's syndrome: a pilot study","volume":"31","author":"M M Zandbelt","year":"2004","journal-title":"J Rheumatol"},{"issue":"07","key":"ref121","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1002\/art.20299","article-title":"Etanercept in Sj\u00f6gren's syndrome: a twelve-week randomized, double-blind, placebo-controlled pilot clinical trial","volume":"50","author":"V Sankar","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"01","key":"ref122","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/14712598.2017.1235698","article-title":"Present and future of biologic drugs in primary Sj\u00f6gren's syndrome","volume":"17","author":"D Sambataro","year":"2017","journal-title":"Expert Opin Biol Ther"},{"issue":"07","key":"ref123","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1136\/annrheumdis-2013-204653","article-title":"Abatacept treatment reduces disease activity in early primary Sj\u00f6gren's syndrome (open-label proof of concept ASAP study)","volume":"73","author":"P M Meiners","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"03","key":"ref124","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1016\/S2665-9913(19)30160-2","article-title":"Abatacept treatment for patients with early active primary Sj\u00f6gren's syndrome: a single-centre, randomised, double-blind, placebo-controlled, phase 3 trial (ASAP-III study)","volume":"2","author":"J FM van Nimwegen","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"ref125","doi-asserted-by":"crossref","first-page":"bcr2014209076","DOI":"10.1136\/bcr-2014-209076","article-title":"Tocilizumab for refractory organising pneumonia associated with Sj\u00f6gren's disease","volume":"2015","author":"A Justet","year":"2015","journal-title":"BMJ Case Rep"},{"issue":"03","key":"ref126","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1136\/annrheumdis-2020-218467","article-title":"Interleukin 6 receptor inhibition in primary Sj\u00f6gren syndrome: a multicentre double-blind randomised placebo-controlled trial","volume":"80","author":"R Felten","year":"2021","journal-title":"Ann Rheum Dis"},{"issue":"03","key":"ref127","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1016\/S2665-9913(19)30135-3","article-title":"Assessment of the anti-CD40 antibody iscalimab in patients with primary Sj\u00f6gren's syndrome: a multicentre, randomised, double-blind, placebo-controlled, proof-of-concept study","volume":"2","author":"B A Fisher","year":"2020","journal-title":"Lancet Rheumatol"},{"issue":"08","key":"ref128","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1093\/rheumatology\/kev005","article-title":"Treatment with belimumab restores B cell subsets and their expression of B cell activating factor receptor in patients with primary Sjogren's syndrome","volume":"54","author":"E Pontarini","year":"2015","journal-title":"Rheumatology (Oxford)"},{"issue":"05","key":"ref129","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1136\/annrheumdis-2018-214720","article-title":"Treatment of primary Sj\u00f6gren's syndrome with ianalumab (VAY736) targeting B cells by BAFF receptor blockade coupled with enhanced, antibody-dependent cellular cytotoxicity","volume":"78","author":"T D\u00f6rner","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"03","key":"ref130","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1056\/NEJMc1900045","article-title":"Tofacitinib in amyopathic dermatomyositis-associated interstitial lung disease","volume":"381","author":"Z Chen","year":"2019","journal-title":"N Engl J Med"},{"issue":"04","key":"ref131","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1093\/rheumatology\/keaa670","article-title":"Tofacitinib counteracts IL-6 overexpression induced by deficient autophagy: implications in Sj\u00f6gren's syndrome","volume":"60","author":"M J Barrera","year":"2021","journal-title":"Rheumatology (Oxford)"},{"issue":"01","key":"ref132","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1186\/s12890-023-02774-0","article-title":"Tofacitinib in the treatment of primary Sj\u00f6gren's syndrome-associated interstitial lung disease: study protocol for a prospective, randomized, controlled and open-label trial","volume":"23","author":"R Gao","year":"2023","journal-title":"BMC Pulm Med"},{"issue":"12","key":"ref133","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1002\/art.40589","article-title":"JAK-1 inhibition suppresses interferon-induced BAFF production in human salivary gland: potential therapeutic strategy for primary Sj\u00f6gren's syndrome","volume":"70","author":"J Lee","year":"2018","journal-title":"Arthritis Rheumatol"},{"issue":"22","key":"ref134","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","article-title":"A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis","volume":"370","author":"T E King Jr","year":"2014","journal-title":"N Engl J Med"},{"issue":"01","key":"ref135","first-page":"91","article-title":"Pirfenidone for primary Sj\u00f6gren's syndrome-related fibrotic interstitial pneumonia","volume":"34","author":"Y Enomoto","year":"2017","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"22","key":"ref136","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","article-title":"Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis","volume":"370","author":"L Richeldi","year":"2014","journal-title":"N Engl J Med"},{"issue":"18","key":"ref137","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","article-title":"Nintedanib in progressive fibrosing interstitial lung diseases","volume":"381","author":"K R Flaherty","year":"2019","journal-title":"N Engl J Med"},{"issue":"26","key":"ref138","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa1903076","article-title":"Nintedanib for systemic sclerosis-associated interstitial lung disease","volume":"380","author":"O Distler","year":"2019","journal-title":"N Engl J Med"}],"container-title":["Seminars in Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0044-1785675.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T10:38:00Z","timestamp":1730803080000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0044-1785675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,15]]},"references-count":136,"journal-issue":{"issue":"03","published-online":{"date-parts":[[2024,5,22]]},"published-print":{"date-parts":[[2024,6]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0044-1785675","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["1069-3424","1098-9048"],"issn-type":[{"value":"1069-3424","type":"print"},{"value":"1098-9048","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,15]]}}}